Sound Income Strategies »

Syros Pharmaceuticals shares owned by Sound Income Strategies

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by Sound Income Strategies from 13F filings

Historical chart of Sound Income Strategies investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by Sound Income Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by Sound Income Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $407 76 5.36
2023-12-31 $592 76 7.79
2023-09-30 $300 76 3.95
2023-06-30 $238 76 3.14
2023-03-31 $203 76 2.67

More positions owned by Sound Income Strategies

Hercules Technology Growth Capital (HTGC)
Sixth Street Specialty Lending (TSLX)
Golub Capital BDC (GBDC)
Ares Capital Corporation (ARCC)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Owl Rock Capital Corporation (OBDC)
Pennantpark Floating Rate Capi (PFLT)
Vaneck Vectors Etf Tr Emerging Mkts Hi (HYEM)
Ishares Jp Mrgn Em Hi Bd (EMHY)
First Tr Exchng Traded Fd Vi Tcw Emerging Mkt (EFIX)
Tidal Etf Tr Sound Enhanced (FXED)
Tidal Etf Tr Sound Equity Inm (DIVY)
Lyondellbasell Industries N Shs - A - (LYB)
Omni (OMC)
International Business Machines (IBM)

View all positions for Sound Income Strategies

Top funds holding Syros Pharmaceuticals

Artal Group
Samsara BioCapital
Avidity Partners Management
Blue Owl Capital Holdings
Point72 Asset Management
Flagship Ventures Management
Vanguard Group
Opaleye Management
Omega Fund Management
Goldman Sachs Group
DAFNA Capital Management
Assenagon Asset Management
Tang Capital Management
Lgt Capital Partners
Two Sigma Investments

View all funds holding Syros Pharmaceuticals